For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| ExAblate Treatment Arm | ExAblate 2000: MR guided focused ultrasound | 8 | None | 8 | 87 | 49 | 87 | View |
| ExAblate Sham Control Arm | ExAblate 2000: MR guided focused ultrasound sham | 0 | None | 0 | 28 | 1 | 28 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Fever | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Deep Vein Thrombosis | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Skin burn | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Numbness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Neuropathy/leg pain | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Pain/discomfort | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Apnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Fracture | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |